top of page
Who We Are
Pioneering Cancer Treatment with
Dye Drug Conjugates.
Lahjavida has developed a novel drug delivery platform called a Dye Drug Conjugate (DDC). This technology enhances cancer treatments by precisely targeting tumors while protecting healthy tissues. Dye Drug Conjugates remain non-toxic during circulation and activate only when they reach cancer cells, ensuring focused treatment.
Discover Lahjavida.
With 25 years of expertise in tumor-targeting dye technology, Lahjavida is pioneering a new approach.
Our Dye Drug Conjugate platform uses a tumor-targeting dye to deliver chemotherapy directly to cancer cells, minimizing harm to healthy tissues. This groundbreaking approach combines proven tumor-targeting dye technology with chemotherapy drug efficacy.
bottom of page